Aldeyra Therapeutics, Inc. (ALDX)
1.34
-0.12
(-8.22%)
USD |
NASDAQ |
Sep 11, 16:00
1.355
+0.02
(+1.12%)
After-Hours: 20:00
Aldeyra Therapeutics Total Assets (Quarterly) : 47.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.54M |
| March 31, 2026 | 66.48M |
| December 31, 2025 | 72.06M |
| September 30, 2025 | 77.80M |
| June 30, 2025 | 84.96M |
| March 31, 2025 | 93.20M |
| December 31, 2024 | 104.61M |
| September 30, 2024 | 117.32M |
| June 30, 2024 | 126.04M |
| March 31, 2024 | 141.30M |
| December 31, 2023 | 148.33M |
| September 30, 2023 | 147.28M |
| June 30, 2023 | 155.62M |
| March 31, 2023 | 168.22M |
| December 31, 2022 | 181.29M |
| September 30, 2022 | 189.69M |
| June 30, 2022 | 201.02M |
| March 31, 2022 | 222.69M |
| December 31, 2021 | 233.23M |
| September 30, 2021 | 247.22M |
| June 30, 2021 | 256.43M |
| March 31, 2021 | 147.31M |
| December 31, 2020 | 83.42M |
| September 30, 2020 | 88.32M |
| June 30, 2020 | 71.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 63.03M |
| December 31, 2019 | 75.57M |
| September 30, 2019 | 77.44M |
| June 30, 2019 | 73.84M |
| March 31, 2019 | 88.13M |
| December 31, 2018 | 95.09M |
| September 30, 2018 | 37.13M |
| June 30, 2018 | 43.29M |
| March 31, 2018 | 40.78M |
| December 31, 2017 | 44.18M |
| September 30, 2017 | 49.23M |
| June 30, 2017 | 26.47M |
| March 31, 2017 | 31.53M |
| December 31, 2016 | 25.19M |
| September 30, 2016 | 29.19M |
| June 30, 2016 | 32.88M |
| March 31, 2016 | 23.44M |
| December 31, 2015 | 28.20M |
| September 30, 2015 | 31.35M |
| June 30, 2015 | 33.88M |
| March 31, 2015 | 15.93M |
| December 31, 2014 | 8.787M |
| September 30, 2014 | 10.35M |
| June 30, 2014 | 11.81M |
| March 31, 2014 | 2.891M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.655M |
| Shareholders Equity (Quarterly) | 37.89M |
| Debt to Equity Ratio | 0.0038 |
| Current Ratio | 4.842 |
| Net Debt Paydown Yield | 2.40% |